Literature DB >> 25697560

Antioxidant properties of melatonin and its potential action in diseases.

Cigdem Karaaslan1, Sibel Suzen.   

Abstract

In recent years, relationship between free radicals and oxidative stress with aging, cancer, atherosclerosis, neurodegenerative disorders, diabetes, and inflammatory diseases became increasingly clear. Confirming the role of oxidants in numerous pathological conditions such as cancer, the antioxidants developed as therapeutics have been proven ineffective. It is well established that melatonin (MLT) and its metabolites are able to function as endogenous free-radical scavengers and broadspectrum antioxidants. Numerous studies also proved the role of MLT and its derivatives in many physiological processes and therapeutic functions, such as the regulation of circadian rhythm and immune functions. The aim of this review is to arouse attention to MLT as a potentially valuable agent in the prevention and/or treatment of some diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25697560     DOI: 10.2174/1568026615666150220120946

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  18 in total

1.  Melatonin alleviates intervertebral disc degeneration by disrupting the IL-1β/NF-κB-NLRP3 inflammasome positive feedback loop.

Authors:  Fan Chen; Guowei Jiang; Hui Liu; Zemin Li; Yuxin Pei; Hua Wang; Hehai Pan; Haowen Cui; Jun Long; Jianru Wang; Zhaomin Zheng
Journal:  Bone Res       Date:  2020-02-18       Impact factor: 13.567

Review 2.  Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities.

Authors:  Wamidh H Talib; Ahmad Riyad Alsayed; Alaa Abuawad; Safa Daoud; Asma Ismail Mahmod
Journal:  Molecules       Date:  2021-04-25       Impact factor: 4.411

Review 3.  The role of melatonin in the molecular mechanisms underlying metaflammation and infections in obesity: A narrative review.

Authors:  Claudia Pivonello; Mariarosaria Negri; Roberta Patalano; Feliciana Amatrudo; Tatiana Montò; Alessia Liccardi; Chiara Graziadio; Giovanna Muscogiuri; Rosario Pivonello; Annamaria Colao
Journal:  Obes Rev       Date:  2021-12-03       Impact factor: 10.867

4.  Application of a validated HPLC-PDA method for the determination of melatonin content and its release from poly(lactic acid) nanoparticles.

Authors:  Leiziani Gnatkowski Martins; Najeh Maissar Khalil; Rubiana Mara Mainardes
Journal:  J Pharm Anal       Date:  2017-05-20

5.  Presence of melatonin in human tears.

Authors:  Gonzalo Carracedo; Carlos Carpena; Pablo Concepción; Victor Díaz; Miguel García-García; Nahla Jemni; Victoria Eugenia Lledó; Marina Martín; Cristina Pastrana; Raquel Pelissier; Albena Veselinova; Xiaoyu Wang; Jesus Pintor
Journal:  J Optom       Date:  2016-04-13

6.  Melatonin counteracts cobalt nanoparticle‑induced cytotoxicity and genotoxicity by deactivating reactive oxygen species‑dependent mechanisms in the NRK cell line.

Authors:  Yake Liu; Xiaoyou Yang; Wei Wang; Xuefei Wu; Hai Zhu; Fan Liu
Journal:  Mol Med Rep       Date:  2017-08-22       Impact factor: 2.952

Review 7.  The Role of Oxidative Stress and Antioxidants in Liver Diseases.

Authors:  Sha Li; Hor-Yue Tan; Ning Wang; Zhang-Jin Zhang; Lixing Lao; Chi-Woon Wong; Yibin Feng
Journal:  Int J Mol Sci       Date:  2015-11-02       Impact factor: 5.923

Review 8.  Genetic Syndromes, Maternal Diseases and Antenatal Factors Associated with Autism Spectrum Disorders (ASD).

Authors:  Asher Ornoy; Liza Weinstein-Fudim; Zivanit Ergaz
Journal:  Front Neurosci       Date:  2016-07-06       Impact factor: 4.677

9.  Melatonin and health: an umbrella review of health outcomes and biological mechanisms of action.

Authors:  Pawel P Posadzki; Ram Bajpai; Bhone Myint Kyaw; Nicola J Roberts; Amnon Brzezinski; George I Christopoulos; Ushashree Divakar; Shweta Bajpai; Michael Soljak; Gerard Dunleavy; Krister Jarbrink; Ei Ei Khaing Nang; Chee Kiong Soh; Josip Car
Journal:  BMC Med       Date:  2018-02-05       Impact factor: 8.775

10.  Melatonin ameliorates H2O2-induced oxidative stress through modulation of Erk/Akt/NFkB pathway.

Authors:  Mahammed Moniruzzaman; Indranath Ghosal; Debjit Das; Suman Bhusan Chakraborty
Journal:  Biol Res       Date:  2018-06-11       Impact factor: 5.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.